Renal Transplant Rejection
Also known as: Rejection; Transplant, Kidney / Kidney Transplant Rejection / Acute allograft nephropathy / Renal transplant rejection (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB00087 | Alemtuzumab | A monoclonal anti-CD52 antibody used in the treatment of B-cell chronic lymphocytic leukemia and relapsing forms of multiple sclerosis. |
DB09312 | Antilymphocyte immunoglobulin (horse) | A primarily IgG immune globulin used to manage allograft rejection in renal transplant patients. |
DB00993 | Azathioprine | An immunosuppressant used to prevent renal transplant rejection, treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis. |
DB06681 | Belatacept | A selective T-cell costimulation blocker used in the prophylaxis of organ rejection in adult patients receiving a kidney transplant. |
DB00091 | Cyclosporine | A steroid-sparing immunosuppressant used in organ and bone marrow transplants as well as inflammatory conditions such as ulcerative colitis, rheumatoid arthritis, and atopic dermatitis. |
DB01590 | Everolimus | A mammalian target of rapamycin (mTOR) kinase inhibitor used to treat various types of malignancies. |
DB01024 | Mycophenolic acid | An immunosuppressant used to prevent organ transplant rejections. |
DB00864 | Tacrolimus | A calcineurin inhibitor used to prevent organ transplant rejection and to treat moderate to severe atopic dermatitis. |